List of SBIR/STTR awards granted to Epigen Biosciences, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in June, 2018 for $1,998,774.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK092005-04 | Phase II | 1,998,774 | June 20, 2018 | |||||||
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in April, 2021 for $1,048,958.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH115529-03 | Phase II | 1,048,958 | April 15, 2021 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in May, 2020 for $299,983.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150986-01A1 | Phase I | 299,983 | May 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in August, 2019 for $1,169,102.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG043243-03 | Phase II | 1,169,102 | August 15, 2019 | |||||||
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in May, 2021 for $1,035,811.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK127879-01A1 | Phase II | 1,035,811 | May 20, 2021 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR072546-01A1 | Phase I | 225,000 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in June, 2021 for $449,984.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG071335-01A1 | Phase I | 449,984 | June 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2021 for $397,398.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK129071-01A1 | Phase I | 397,398 | September 20, 2021 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2020 for $375,033.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK123920-01A1 | Phase I | 375,033 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2018 for $298,946.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK117758-01A1 | Phase I | 298,946 | September 5, 2018 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2019 for $390,335.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DE029379-01 | Phase I | 390,335 | September 19, 2019 | |||||||
A STTR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2017 for $417,267.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS098903-01A1 | Phase I | 417,267 | September 28, 2017 | |||||||
A STTR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2017 for $834,798.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41MH115529-01 | Phase I | 834,798 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in September, 2015 for $228,661.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK105654-01A1 | Phase I | 228,661 | September 15, 2015 | |||||||
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in September, 2014 for $1,453,632.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK092005-02A1 | Phase II | 1,453,632 | September 1, 2014 | |||||||
A STTR Phase I contract was awarded to Epigen Biosciences, Inc. for $726,746.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AG043243-01 | Phase I | 726,746 | ||||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. for $389,603.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK092005-01A1 | Phase I | 389,603 | ||||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. for $288,297.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA174019-01A1 | Phase I | 288,297 | ||||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA183195-01 | Phase I | 225,000 | ||||||||
A STTR Phase I contract was awarded to Epigen Biosciences, Inc. for $225,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS087684-01 | Phase I | 225,000 | ||||||||
A STTR Phase I contract was awarded to Epigen Biosciences, Inc. for $244,999.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS086244-01A1 | Phase I | 244,999 | ||||||||
A SBIR Phase I contract was awarded to Epigen Biosciences, Inc. in May, 2023 for $448,110.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK134242-01A1 | Phase I | 448,110 | May 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Epigen Biosciences, Inc. in September, 2023 for $971,732.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK129071-02 | Phase II | 971,732 | September 1, 2023 |
